B2B pharmaceutical platform i’SUPPLY, located in Egypt, has secured US $1.5 million in a pre-seed round to grow throughout the Middle East and Africa.
Ibrahim Emam, Malek Sultan, and Moustafa Zaki founded i’SUPPLY in 2021 with the goal of digitising the pharmaceutical industry by offering a one-stop-shop solution to promptly anticipate and deal with supply chain problems.
“With an initial launch late in 2021, i’SUPPLY aims to transform the medicine wholesale distribution in the MENA region and Africa by focusing on supporting and empowering the mid and small-sized wholesalers and pharmacies,” Emam said.
“The company is building a reliable and integrated network which enhances and augments traditional brick and mortar platforms with data-driven disruptive sales, distribution, and procurement solutions that optimise the procurement processes and provide a one-stop-shop solution that supports industry’s stakeholders to quickly predict and overcome supply chain disruptions.”
Pre-seed funding for i’SUPPLY totalled US $1.5 million, with Disruptech Ventures serving as the round’s lead investor. The firm has had rapid development since its introduction, adding 5,000 pharmacies and producing more than 50,000 sales. It now plans to spread throughout Egypt, aiming to reach 60,000 shops. In addition to establishing distribution and finance services, i’SUPPLY intends to grow throughout Africa and the MENA area.
“We at Disruptech are very excited to be part of iSupply’s journey, we always stand by and back strong founders like Ibrahim and i’SUPPLY’s founding team. We believe that Ibrahim and his team will create real positive disruption in the industry,” said Malek Sultan, Disruptech’s co-founder and partner.
